NCT01987999已完成2 期
Phase II Eradication of Prostate Cancer Using F-989
Optimal Health Research0 个研究点目标入组 60 人开始时间: 2013年2月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 主要终点
- Gleason Score
研究概览
简要总结
The purpose of this study is to confirm the findings of an early study with prostate cancer and to expand our knowledge of treating prostate cancer using F-989.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 75 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of prostate cancer
- •Referred to the study by their treating physician
排除标准
- •Any type of treatment before starting study
研究组 & 干预措施
Acetogenins
Experimental
Acetogenins twice (BID) per day for 12 months
干预措施: Acetogenins (Dietary Supplement)
结局指标
主要结局
Gleason Score
时间窗: 1 year
A Gleason Score is obtained from the results of a transrectal needle biopsy of the prostate.
次要结局
- Prostate Specific Antigens (PSA)(1 year)